Results 241 to 250 of about 22,201 (271)

Utilization of Opioid Agonist Therapies in Canada

Canadian Journal of Health Technologies, 2023
Canada continues to experience an opioid crisis that has had a devastating impact on public health, highlighting the importance of management strategies for opioid use disorder (OUD). Several opioid agonist therapies (OATs) for the management of OUD are available in Canada, including recent approvals of new brand name drugs and generic versions of ...
Ari Mendell, Chris Vannabouathong, Kim Le, Peter Dyrda   +3 more
openaire   +1 more source

Barriers to accessing opioid agonist therapy in pregnancy

American Journal of Obstetrics & Gynecology MFM, 2020
The incidence of opioid use disorder during pregnancy has risen dramatically in the last couple of decades. Despite the safety and efficacy of treatment for opioid use during pregnancy, pregnant women often cannot access treatment.This study aimed to determine the availability of opioid agonist therapy to pregnant women in Missouri and Illinois and to ...
Bronwyn S, Bedrick, Carly, O'Donnell, Christine M, Marx, Hayley, Friedman, Ebony B, Carter, Molly J, Stout, Jeannie C, Kelly   +6 more
openaire   +2 more sources

Punitive discontinuation of opioid agonist therapy during incarceration

International Journal of Prisoner Health, 2020
Purpose The prevalence of substance use disorders among incarcerated individuals in Canada is substantially higher than in the general population. Many incarcerated individuals with opioid use disorder remain untreated due to inadequate access to opioid agonist therapy (OAT).
Allison, Marmel, Nikki, Bozinoff
openaire   +2 more sources

Mal/adaptations: A qualitative evidence synthesis of opioid agonist therapy during major disruptions

International Journal of Drug Policy, 2022
Opioid agonist therapy (OAT) has been severely disrupted by the COVID-19 pandemic. The risks of opioid withdrawal, overdose, and diversion have increased, so there is an urgent need to adapt OAT to best support people who use drugs (PWUD).
Darren K Cheng, Umair Majid, Ross E G Upshur   +2 more
exaly   +3 more sources

Managing Opioid Agonist Therapy in the Post-Soviet Limbo

Contemporary Drug Problems, 2021
According to Dante, “Limbo” is the first circle of Hell located at its edge. Unlike other residents of Hell, the Limbo population suffers no torment other than their lack of hope. We argue that a lack of hope in post-Soviet Ukraine is expressed by a lack of conditions for a better future since the past is overrepresented in the present.
Alexandra Dmitrieva, Vladimir Stepanov, Alyona Mazhnaya   +2 more
openaire   +1 more source

Psychotherapeutic Benefits of Opioid Agonist Therapy

Journal of Addictive Diseases, 2008
Opioids have been used for centuries to treat a variety of psychiatric conditions with much success. The so-called "opium cure" lost popularity in the early 1950s with the development of non-addictive tricyclic antidepressants and monoamine oxidase inhibitors. Nonetheless, recent literature supports the potent role of methadone, buprenorphine, tramadol,
openaire   +2 more sources

[Opioid Agonist Therapy (OAT) for opioid dependency].

Therapeutische Umschau. Revue therapeutique, 2020
Opioid Agonist Therapy (OAT) for opioid dependency Abstract. The process of evaluating the necessity of an Opioid Agonist Therapy (OAT) is relatively simple. Once the criteria for an opioid dependency according to the ICD-10 (or DSM V) are met, treatment should be offered. Adequate individual dosing of the opioid agonist is crucial to treatment success.
Patrick, Köck, Johannes, Strasser
openaire   +1 more source

Posttraumatic stress disorder in opioid agonist therapy: A review.

Psychological Trauma: Theory, Research, Practice, and Policy, 2018
Posttraumatic stress disorder (PTSD) and opioid use disorder (OUD) co-occur at high rates, and this co-occurrence is associated with a range of problems related to mental and physical health. OUD is commonly treated with opioid agonist therapies (OAT), which have been shown to be effective for reducing opiate use and related negative health ...
Anthony H, Ecker, Natalie, Hundt
openaire   +2 more sources

Combatting the Opioid Crisis From Prison: Initiating Opioid Agonist Therapy

Journal of Forensic Nursing, 2018
ABSTRACT Presented is a case report of a young man dependent on fentanyl who did not receive opioid agonist therapy (OAT) during incarceration. Highlighted are the barriers to accessing OAT in custody, which exacerbates problems with drug-seeking behavior, diversion, and recidivism.
openaire   +2 more sources

Factors Associated With Preferences for Opioid Agonist Therapies Among People Dependent on Opioids

Drug and Alcohol Review
ABSTRACT Introduction Opioid agonist therapies (OAT) reduce adverse outcomes of illicit opioid use, with individual preferences potentially improving treatment outcomes. We explored preferences for OAT and associated factors in a national sample of people with opioid dependence.
M. J. Stowe, Anna Conway, Frederick L. Altice, Samantha Colledge‐Frisby, Phillip Read, Mark Montebello, Gilbert Whitton, Jeremy Hayllar, Mark Daglish, Victoria Cock, Michael Christmass, Sione Crawford, Charles Henderson, Gregory J. Dore, Chris Gough, Michael Farrell, Louisa Degenhardt, Jason Grebely   +17 more
openaire   +4 more sources